Key Drivers
- Strong FCF
- High SG&A
- Quarter weakness
AIAI Summary
NHC has shifted from a dividend/defensive story to a cash‑flow–driven operational growth thesis—16% revenue growth and strong annual FCF mean valuation now hinges on execution (cost control and margin stability). Monitor the next two quarters for margin re‑expansion and consistent quarterly FCF (or else the current multiple and $155–158 support risk re‑rating).
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong FCF
- •High SG&A
- •Quarter weakness
NHC shows solid balance-sheet strength and strong annual cash generation with attractive ROIC, but high operating costs and recent quarterly margin compression are key risks.
Price Behavior
Key Price Behavior Insights:
- •Below 21‑day avg
- •Limited momentum
- •Resistance near $172.83
Over the last month NHC is neutral-to-slightly-bearish: last close $158.81 sits modestly below the last month average $161.90 with only ~+0.6% net change, support around $155–$158 and clear resistance at $172.83 amid moderate ~10–11% intraperiod volatility.
~10–11% high/low range over last month, signaling moderate intraperiod volatility
Sentiment & News
Key News Insights:
- •Strong revenue growth
- •Same‑facility improvement
- •Minor investor trim
NHC posted 16.1% revenue growth to $1.518B in 2025 driven by same‑facility gains, while Dimensional's 0.4% stake trim signals only a minor institutional adjustment.
The results reinforce NHC's operational momentum and should support the stock's fundamental case, with the small institutional sell‑down unlikely to materially alter investor confidence
Similar Companies in Healthcare
Other companies in the same sector with AI ratings